Literature DB >> 15694465

Drug-induced vascular injury--a quest for biomarkers.

William Kerns1, Lester Schwartz, Kerry Blanchard, Scott Burchiel, David Essayan, Eric Fung, Robert Johnson, Mike Lawton, Calvert Louden, James MacGregor, Fred Miller, Prakash Nagarkatti, Don Robertson, Paul Snyder, Heath Thomas, Bernard Wagner, Anthony Ward, Jun Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15694465     DOI： 10.1016/j.taap.2004.08.001

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  10 in total

1.  Necrotising vasculitis of the skin associated with an herbal medicine containing amfepramone.

Authors:  Ulrike Halbsguth; Stefanie Schwanda; Thomas Lehmann; Sonja Ostheeren-Michaelis; Karin Fattinger
Journal:  Eur J Clin Pharmacol       Date:  2009-03-05       Impact factor: 2.953

2.  A bilayer small diameter in vitro vascular model for evaluation of drug induced vascular injury.

Authors:  David M Hoganson; Eric B Finkelstein; Gwen E Owens; James C Hsiao; Kurt Y Eng; Katherine M Kulig; Ernest S Kim; Tatiana Kniazeva; Irina Pomerantseva; Craig M Neville; James R Turk; Bernard Fermini; Jeffrey T Borenstein; Joseph P Vacanti
Journal:  Biomicrofluidics       Date:  2016-10-12       Impact factor: 2.800

3.  A portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow control.

Authors:  J R Coppeta; M J Mescher; B C Isenberg; A J Spencer; E S Kim; A R Lever; T J Mulhern; R Prantil-Baun; J C Comolli; J T Borenstein
Journal:  Lab Chip       Date:  2016-12-20       Impact factor: 6.799

Review 4.  Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.

Authors:  Brian R Berridge; Vasanthi Mowat; Hirofumi Nagai; Abraham Nyska; Yoshimasa Okazaki; Peter J Clements; Matthias Rinke; Paul W Snyder; Michael C Boyle; Monique Y Wells
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

Review 5.  Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

Authors:  Jacqueline M Tarrant
Journal:  Toxicol Sci       Date:  2010-05-06       Impact factor: 4.849

6.  Toxic effects of xylazine on endothelial cells in combination with cocaine and 6-monoacetylmorphine.

Authors:  L A Silva-Torres; C Vélez; J Lyvia Alvarez; J G Ortiz; B Zayas
Journal:  Toxicol In Vitro       Date:  2014-07-08       Impact factor: 3.500

7.  Changes in serum cytokine levels, hepatic and intestinal morphology in aflatoxin B1-induced injury: modulatory roles of melatonin and flavonoid-rich fractions from Chromolena odorata.

Authors:  Fadeyemi Joseph Akinrinmade; Akinleye Stephen Akinrinde; Adetayo Amid
Journal:  Mycotoxin Res       Date:  2016-01-22       Impact factor: 3.833

8.  Xylazine as a drug of abuse and its effects on the generation of reactive species and DNA damage on human umbilical vein endothelial cells.

Authors:  Luz Silva-Torres; Christian Veléz; Lyvia Alvarez; Beatriz Zayas
Journal:  J Toxicol       Date:  2014-11-11

9.  The effect of curcumin on some cytokines, antioxidants and liver function tests in rats induced by Aflatoxin B1.

Authors:  Durmus Hatipoglu; Ercan Keskin
Journal:  Heliyon       Date:  2022-07-10

10.  Transient Reduction of FMD-Response and L-Arginine Accompanied by Increased Levels of E-Selectin, VCAM, and ICAM after Prolonged Strenuous Exercise.

Authors:  Christoffer Nyborg; Helene Støle Melsom; Martin Bonnevie-Svendsen; Jørgen Melau; Ingebjørg Seljeflot; Jonny Hisdal
Journal:  Sports (Basel)       Date:  2021-06-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.